<?xml version="1.0" encoding="utf-8" ?>
<INTERACTIONS>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>246-GLIMEPIRIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="GLIMEPIRIDE" rxcui="25789">
<ATC code="A10BB12" />
<ATC code="A10BD06" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="CLARITHROMYCIN" rxcui="21212">
<ATC code="J01FA09" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of hypoglycemia due to increase of the absorption and of the plasma concentrations of the antidiabetic. </DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
<INTERACTION>
<SOURCE>
<CLINICAL_SOURCE>ANSM</CLINICAL_SOURCE>
<SOURCE_FILE>246-GLIMEPIRIDE.html
</SOURCE_FILE>
</SOURCE>
<DRUG1>
<DRUG name="GLIMEPIRIDE" rxcui="25789">
<ATC code="A10BB12" />
<ATC code="A10BD06" />
</DRUG>
</DRUG1>
<DRUG2>
<DRUG name="ERYTHROMYCIN" rxcui="4053">
<ATC code="D10AF02" />
<ATC code="D10AF52" />
<ATC code="J01FA01" />
<ATC code="S01AA17" />
</DRUG>
</DRUG2>
<DESCRIPTION>Risk of hypoglycemia due to increase of the absorption and of the plasma concentrations of the antidiabetic</DESCRIPTION>
<SEVERITY>Precaution for use</SEVERITY>
<COMMENT></COMMENT>
</INTERACTION>
</INTERACTIONS>
